News

Filter

Current filters:

Merck & Co

51 to 60 of 97217 results

Lightlake in deal with Adapt Pharma subsidiary

16-12-2014

UK biopharma firm Lightlake Therapeutics has entered into a license agreement with Adapt Pharma Operations,…

Adapt PharmaLicensingLightlake TherapeuticsNaloxoneNeurologicalPharmaceutical

CMC Biologics and OncoSynergy link on Ebola drug development and manufacture

CMC Biologics and OncoSynergy link on Ebola drug development and manufacture

16-12-2014

Denmark and USA-based contract manufacturers CMC Biologics and US biopharma start-up OncoSynergy have…

Anti-viralsBiotechnologyCMC BiologicsOncoSynergyOS2966ProductionResearchTropical diseases

Ranbaxy may establish production in Russia

Ranbaxy may establish production in Russia

16-12-2014

Generic pharma company Ranbaxy, one of India’s largest drugmakers which is in the process of being…

Antibiotics and Infectious diseasesGenericsNeurologicalProductionRanbaxyRussia

Neovacs' Phase IIb study of TNF-Kinoid in rheumatoid arthritis fails to meet primary endpoints

Neovacs' Phase IIb study of TNF-Kinoid in rheumatoid arthritis fails to meet primary endpoints

16-12-2014

French autoimmune specialist Neovacs says that its Phase IIb trial of TNF-Kinoid in rheumatoid arthritis…

BiotechnologyFranceImmunologicalsNeovacsResearchTNF-Kinoid

Trade groups call for integrated life science strategy ahead of European Commission Work Program

Trade groups call for integrated life science strategy ahead of European Commission Work Program

16-12-2014

European research and generic/biosimilar industry associatins have called for an integrated life science…

Advocacy groupsCompetitivenessEuropePharmaceuticalRegulation

Curie-Cancer renews research partnership with GamaMabs Pharma for ovarian cancer drug

Curie-Cancer renews research partnership with GamaMabs Pharma for ovarian cancer drug

16-12-2014

Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities,…

BiotechnologyFranceGamaMabs PharmaOncologyResearch

Spark Therapeutics appoints Rogerio Vivaldi as its first chief commercial officer

Spark Therapeutics appoints Rogerio Vivaldi as its first chief commercial officer

16-12-2014

Late-stage gene therapy company, Spark Therapeutics, has appointed Rogerio Vivaldi as its first chief…

BoardroomGene therapyGenzymeRogerio VivaldiSpark Therapeutics

Novartis gains US FDA approval of Signifor for acromegaly

Novartis gains US FDA approval of Signifor for acromegaly

16-12-2014

The US Food and Drug Administration has approved Swiss pharma giant Novartis’ Signifor (pasireotide)…

NovartisPharmaceuticalRare diseasesRegulationSigniforUSA

51 to 60 of 97217 results

Back to top